Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Biontech Se ADR (NQ: BNTX ) 87.95 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Apr 29, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 10 Open 87.95 Bid (Size) 88.13 (2) Ask (Size) 88.56 (2) Prev. Close 87.95 Today's Range 87.95 - 87.95 52wk Range 85.21 - 125.83 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle April 26, 2024 Acuitas Therapeutics settles lawsuit with CureVac over COVID-19 vaccine patents. Legal disputes unfold among biotech giants Pfizer, BioNTech, and CureVac, as GSK joins the fray, alleging patent... Via Benzinga Topics Intellectual Property Lawsuit Exposures COVID-19 Financial Intellectual Property What's Going On With Pfizer Stock On Thursday? April 25, 2024 GSK initiates legal proceedings against Pfizer and BioNTech over alleged COVID-19 vaccine patent infringement, intensifying high-stakes legal battles in the U.S. Via Benzinga Topics Intellectual Property Exposures COVID-19 Intellectual Property Performance YTD -21.71% -21.71% 1 Month -5.55% -5.55% 3 Month -8.17% -8.17% 6 Month -5.68% -5.68% 1 Year -21.47% -21.47% More News Read More Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown April 23, 2024 Via Benzinga Topics Intellectual Property Exposures COVID-19 Intellectual Property BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024 April 22, 2024 From BioNTech SE Via GlobeNewswire Assessing BioNTech: Insights From 11 Financial Analysts April 17, 2024 Via Benzinga Cracking The Code: Understanding Analyst Reviews For BioNTech March 21, 2024 Via Benzinga Bill Gates Called For A 'Universal Flu Vaccine,' Now The CDC Director Says The Organization Is 'Activated' After Issuing Bird Flu Alert April 12, 2024 Via Benzinga Election Year Encore: Can 2020’s Top 7 Stock Winners Repeat Their Performance in 2024? April 09, 2024 Via InvestorPlace Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancer April 07, 2024 From BioNTech SE Via GlobeNewswire Earnings Outlook For BioNTech March 19, 2024 Via Benzinga CureVac, GS Partner Release Data On Influenza Vaccine Study April 04, 2024 Via Benzinga The 3 Best Bargain Stocks to Buy in Q2 2024 March 31, 2024 Via InvestorPlace 3 Biotech Stocks to Buy for the Next Bull Run: March 2024 March 26, 2024 Via InvestorPlace BioNTech Se (BNTX) Q4 2023 Earnings Call Transcript March 20, 2024 Via The Motley Fool Topics Earnings Exposures Financial Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session March 20, 2024 Via Benzinga BioNTech Touts Its Oncology Shift After Reporting Disappointing Fourth Quarter Financials March 20, 2024 Via Benzinga Exposures COVID-19 Stocks Quietly Higher As Central Bank Wraps Up Meeting March 20, 2024 Via Talk Markets Topics Economy Exposures Interest Rates BNTX Stock Earnings: BioNTech Misses EPS, Misses Revenue for Q4 2023 March 20, 2024 Via InvestorPlace BioNTech Tumbles As Fourth-Quarter Sales Dive 65% And Miss Forecasts March 20, 2024 Via Investor's Business Daily Why Is BioNTech Stock Trading Lower On Wednesday? March 20, 2024 Via Benzinga US Stock Futures Stall As Traders Await Fed Chair Powell's Decision; Analyst Sees S&P 500 Showing 'Signs Of Near-Term Top' March 20, 2024 Via Benzinga Topics Economy Stocks Exposures Interest Rates US Equities BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update March 20, 2024 From BioNTech SE Via GlobeNewswire BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer March 20, 2024 From BioNTech SE Via GlobeNewswire Earnings Scheduled For March 20, 2024 March 20, 2024 Via Benzinga Billionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfolio March 13, 2024 Via InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
